Global Cardiovascular Information System (CVIS) Market Research Report- Forecast till 2027

Table of Contents

LIST OF CONTENTS 1 EXECUTIVE SUMMARY 18 2 MARKET INTRODUCTION 19 2.1 SCOPE OF THE STUDY 19 2.2 RESEARCH OBJECTIVE 19 2.3 MARKET STRUCTURE 19 2.4 ASSUMPTIONS & LIMITATIONS 20 3 RESEARCH METHODOLOGY 21 3.1 DATA MINING 21 3.2 SECONDARY RESEARCH 22 3.3 PRIMARY RESEARCH 23 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24 3.5 FORECASTING TECHNIQUES 24 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26 3.6.1 BOTTOM-UP APPROACH 27 3.6.2 TOP-DOWN APPROACH 27 3.7 DATA TRIANGULATION 28 3.8 VALIDATION 28 4 MARKET DYNAMICS 29 4.1 OVERVIEW 29 4.2 DRIVERS 30 4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES 30 4.2.2 GROWING GOVERNMENT INITIATIVES TOWARDS THE IMPLEMENTATION OF ELECTRONIC HEALTH RECORD SYSTEM 30 4.2.3 TECHNOLOGICAL ADVANCEMENTS 30 4.2.4 RISING DEMAND FOR DATA-DRIVEN TECHNOLOGIES 31 4.3 RESTRAINTS 32 4.3.1 HIGH COST OF CVIS FOLLOWED BY THE NEED FOR TRAINING 32 4.3.2 RESTRAINT IMPACT ANALYSIS 32 4.4 OPPORTUNITIES 32 4.4.1 EMERGING MARKETS OF CVIS 32 5 MARKET FACTOR ANALYSIS 33 5.1 VALUE CHAIN ANALYSIS 33 5.1.1 R&D 34 5.1.2 MANUFACTURING 34 5.1.3 DISTRIBUTION AND SALES 34 5.1.4 POST-SALES MONITORING 34 5.2 PORTER'S FIVE FORCES MODEL 35 5.2.1 BARGAINING POWER OF SUPPLIERS 35 5.2.2 BARGAINING POWER OF BUYERS 36 5.2.3 THREAT OF NEW ENTRANTS 36 5.2.4 THREAT OF SUBSTITUTES 36 5.2.5 INTENSITY OF RIVALRY 36 5.3 IMPACT OF COVID-19 ON THE CARDIOVASCULAR INFORMATION SYSTEM MARKET 36 5.3.1 OVERVIEW 36 5.3.2 IMPACT ON PRIVACY 37 5.3.3 IMPACT ON TECHNOLOGY 37 5.3.4 IMPACT ON DEMAND 37 6 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT 38 6.1 OVERVIEW 38 6.2 SOFTWARE 39 6.3 SERVICES 39 6.4 HARDWARE 40 7 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE 41 7.1 OVERVIEW 41 7.2 CLOUD-BASED/WEB-BASED 42 7.3 ON-PREMISE 42 8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION 43 8.1 OVERVIEW 43 8.2 CARDIAC AND PERIPHERAL CATHETERIZATION 44 8.3 ECHOCARDIOGRAPHY 45 8.4 HEMODYNAMICS MONITORING 45 8.5 ELECTROPHYSIOLOGY 46 8.6 VASCULAR ULTRASOUND 46 8.7 NUCLEAR CARDIOLOGY 47 8.8 ECG/STRESS/HOLTER MANAGEMENT 47 8.9 OTHERS 48 9 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER 49 9.1 OVERVIEW 49 9.2 HOSPITAL & CLINICS 50 9.3 DIAGNOSTIC LABORATORIES 50 9.4 CARDIAC CATH LABS 51 9.5 OTHERS 51 10 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION 52 10.1 OVERVIEW 52 10.2 AMERICAS 53 10.3 NORTH AMERICA 56 10.3.1 US 58 10.3.2 CANADA 59 10.3.3 LATIN AMERICA 61 10.4 EUROPE 63 10.4.1 WESTERN EUROPE 65 10.4.1.1 GERMANY 68 10.4.1.2 FRANCE 69 10.4.1.3 UK 71 10.4.1.4 ITALY 72 10.4.1.5 SPAIN 74 10.4.1.6 REST OF WESTERN EUROPE 76 10.4.2 EASTERN EUROPE 77 10.5 ASIA-PACIFIC 79 10.5.1 CHINA 81 10.5.2 INDIA 83 10.5.3 JAPAN 84 10.5.4 AUSTRALIA 86 10.5.5 SOUTH KOREA 87 10.5.6 REST OF ASIA-PACIFIC 89 10.6 MIDDLE EAST & AFRICA 90 10.6.1 MIDDLE EAST 93 10.6.2 AFRICA 94 11 COMPETITIVE LANDSCAPE 96 11.1 OVERVIEW 96 11.2 MAJOR PLAYERS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 96 11.3 COMPETITIVE BENCHMARKING 97 11.4 COMPETITOR DASHBOARD 98 11.5 DEVELOPMENTS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 98 11.5.1 ACQUISITION 98 11.5.2 COLLABORATION 99 11.5.3 PRODUCT LAUNCH 99 11.5.4 PARTNERSHIP 99 11.6 FINANCIAL MATRIX 100 12 COMPANY PROFILES 101 12.1 GE HEALTHCARE 101 12.1.1 COMPANY OVERVIEW 101 12.1.2 FINANCIAL OVERVIEW 102 12.1.3 PRODUCTS/SERVICES OFFERED 102 12.1.4 KEY DEVELOPMENTS 103 12.1.5 SWOT ANALYSIS 103 12.1.6 KEY STRATEGIES 103 12.2 SIEMENS HEALTHINEERS 104 12.2.1 COMPANY OVERVIEW 104 12.2.2 FINANCIAL OVERVIEW 105 12.2.3 PRODUCTS/SERVICES OFFERED 105 12.2.4 KEY DEVELOPMENTS 106 12.2.5 SWOT ANALYSIS 106 12.2.6 KEY STRATEGIES 106 12.3 KONINKLIJKE PHILIPS NV 107 12.3.1 COMPANY OVERVIEW 107 12.3.2 FINANCIAL OVERVIEW 108 12.3.3 PRODUCTS/SERVICES OFFERED 108 12.3.4 KEY DEVELOPMENTS 109 12.3.5 SWOT ANALYSIS 109 12.3.6 KEY STRATEGIES 109 12.4 FUJIFILM HOLDINGS CORPORATION 110 12.4.1 COMPANY OVERVIEW 110 12.4.2 FINANCIAL OVERVIEW 111 12.4.3 PRODUCTS/SERVICES OFFERED 111 12.4.4 KEY DEVELOPMENTS 112 12.4.5 SWOT ANALYSIS 112 12.4.6 KEY STRATEGIES 112 12.5 MCKESSON CORPORATION 113 12.5.1 COMPANY OVERVIEW 113 12.5.2 FINANCIAL OVERVIEW 114 12.5.3 PRODUCTS/SERVICES OFFERED 114 12.5.4 KEY DEVELOPMENTS 115 12.5.5 SWOT ANALYSIS 115 12.5.6 KEY STRATEGIES 116 12.6 CERNER CORPORATION 117 12.6.1 COMPANY OVERVIEW 117 12.6.2 FINANCIAL OVERVIEW 117 12.6.3 PRODUCTS OFFERED 118 12.6.4 KEY DEVELOPMENTS 118 12.6.5 SWOT ANALYSIS 119 12.6.6 KEY STRATEGIES 119 12.7 IBM WATSON HEALTH 120 12.7.1 COMPANY OVERVIEW 120 12.7.2 FINANCIAL OVERVIEW 121 12.7.3 PRODUCTS OFFERED 121 12.7.4 KEY DEVELOPMENTS 122 12.7.5 SWOT ANALYSIS 122 12.7.6 KEY STRATEGIES 123 12.8 LUMEDX 124 12.8.1 COMPANY OVERVIEW 124 12.8.2 FINANCIAL OVERVIEW 124 12.8.3 PRODUCTS OFFERED 124 12.8.4 KEY DEVELOPMENTS 124 12.8.5 SWOT ANALYSIS 125 12.8.6 KEY STRATEGIES 125 12.9 AGFA-GEVAERT N.V. 126 12.9.1 COMPANY OVERVIEW 126 12.9.2 FINANCIAL OVERVIEW 126 12.9.3 PRODUCTS OFFERED 126 12.9.4 KEY DEVELOPMENTS 127 12.9.5 SWOT ANALYSIS 127 12.9.6 KEY STRATEGIES 127 12.10 DIGISONICS INC. 128 12.10.1 COMPANY OVERVIEW 128 12.10.2 FINANCIAL OVERVIEW 128 12.10.3 PRODUCTS OFFERED 128 12.10.4 KEY DEVELOPMENTS 128 12.10.5 SWOT ANALYSIS 129 12.10.6 KEY STRATEGIES 129 12.11 CARESTREAM HEALTH 130 12.11.1 COMPANY OVERVIEW 130 12.11.2 FINANCIAL OVERVIEW 130 12.11.3 PRODUCTS/SERVICES OFFERED 130 12.11.4 KEY DEVELOPMENTS 130 12.11.5 SWOT ANALYSIS 131 12.11.6 KEY STRATEGIES 131 12.12 EPIC SYSTEMS CORPORATION 132 12.12.1 COMPANY OVERVIEW 132 12.12.2 FINANCIAL OVERVIEW 132 12.12.3 PRODUCTS OFFERED 132 12.12.4 KEY DEVELOPMENTS 132 12.12.5 SWOT ANALYSIS 133 12.12.6 KEY STRATEGIES 133 12.13 SCIMAGE, INC. 134 12.13.1 COMPANY OVERVIEW 134 12.13.2 FINANCIAL OVERVIEW 134 12.13.3 PRODUCTS/SERVICES OFFERED 134 12.13.4 KEY DEVELOPMENTS 134 12.13.5 SWOT ANALYSIS 135 12.13.6 KEY STRATEGIES 135 13 APPENDIX 136 13.1 REFERENCES 136 13.2 RELATED REPORTS 136